Bisphosphonate use in women and the risk of atrial fibrillation: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 142, Issue 3, 2010, Pages 213-217

  Bhuriya, Rohit ^a   Singh, Mukesh ^a   Molnar, Janos ^a   Arora, Rohit ^a   Khosla, Sandeep ^a  

^a The Chicago Medical College   (United States)

Author keywords

Atrial fibrillation; Bisphosphonates; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; PLACEBO; RISEDRONIC ACID; UNCLASSIFIED DRUG; ZOLENDRONIC ACID;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ATRIAL FIBRILLATION; CHEMICALLY INDUCED; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTOR;

ATRIAL FIBRILLATION; DIPHOSPHONATES; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS;

EID: 77953527990     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.11.041     Document Type: Review

References (31)

1. A.D. Woolf, and K. Akesson Preventing fractures in elderly people BMJ 327 7406 Jul 12 2003 89 95 Review
2. C. MacLean, S. Newberry, and M. Maglione, et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis Ann Intern Med 148 3 Feb 5 2008 197 213
3. L. Giangregorio, A. Papaioannou, and A. Cranney, et al. Fragility fractures and the osteoporosis care gap: an international phenomenon Semin Arthritis Rheum 35 5 Apr 2006 293 305
4. D.M. Black, P.D. Delmas, and R. Eastell, et al. HORIZON pivotal fracture trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis N Engl J Med 356 18 May 3 2007 1809 1822
5. S.R. Cummings, A.V. Schwartz, and D.M. Black Alendronate and atrial fibrillation N Engl J Med 356 18 May 3 2007 1895 1896
6. S.R. Heckbert, G. Li, and S.R. Cummings, et al. Use of alendronate and risk of incident atrial fibrillation in women Arch Intern Med 168 8 Apr 28 2008 826 831
7. W.B. Kannel, and E.J. Benjamin Status of the epidemiology of atrial fibrillation Med Clin North Am 92 1 Jan 2008 17 40 ix. Review
8. J. Friberg, P. Buch, and H. Scharling, et al. Rising rates of hospital admissions for atrial fibrillation Epidemiology 14 6 Nov 2003 666 672
9. W.A. Wattigney, G.A. Mensah, and J.B. Croft Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention Circulation 108 6 Aug 12 2003 711 716
10. S. Stewart, K. MacIntyre, and M.M. MacLeod, et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996 Eur Heart J 22 8 Apr 2001 693 701
11. R.H. Falk Atrial fibrillation N Engl J Med 344 14 Apr 5 2001 1067 1078 Review. Erratum in: N Engl J Med 2001 Jun 14;344(24):1876
12. E.J. Benjamin, D. Levy, and S.M. Vaziri, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 11 Mar 16 1994 840 844
13. A.S. Go, E.M. Hylek, and K.A. Phillips, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study JAMA 285 18 May 9 2001 2370 2375
14. B.M. Psaty, T.A. Manolio, and L.H. Kuller, et al. Incidence of and risk factors for atrial fibrillation in older adults Circulation 96 7 Oct 7 1997 2455 2461
15. B. Ruo, A.M. Capra, and N.G. Jensvold, et al. Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study J Am Coll Cardiol 43 3 Feb 4 2004 429 435
16. C.G. Solomon Bisphosphonates and osteoporosis N Engl J Med 346 9 Feb 28 2002 642
17. L.B. Tankó, C. Christiansen, and D.A. Cox, et al. Relationship between osteoporosis and cardiovascular disease in postmenopausal women J Bone Miner Res 20 11 Nov 2005 1912 1920 Electronic publication 2005 Jul 18. Erratum in: J Bone Miner Res. 2006 Feb;21(2):352
18. K.W. Lyles, C.S. Colón-Emeric, and J.S. Magaziner, et al. HORIZON recurrent fracture trial. Zoledronic acid and clinical fractures and mortality after hip fracture N Engl J Med 357 18 Nov 1 2007 1799 1809
19. H.T. Sørensen, S. Christensen, and F. Mehnert, et al. Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study BMJ 336 7648 Apr 12 2008 813 816
20. R.P. Harris, M. Helfand, and S.H. Woolf, et al. Current methods of the US Preventive Services Task Force: a review of the process Am J Prev Med 20 3 Suppl 2001 21 35
21. R. Karam, J. Camm, and M. McClung Yearly zoledronic acid in postmenopausal osteoporosis N Engl J Med 357 7 Aug 16 2007 712 713 author reply 714-5
22. B. Abrahamsen, P. Eiken, and K. Brixen Atrial fibrillation in fracture patients treated with oral bisphosphonates J Intern Med 265 5 May 2009 581 592
23. S.D. Vasikaran Bisphosphonates: an overview with special reference to alendronate Ann Clin Biochem 38 Pt 6 Nov 2001 608 623 Review
24. K.E. Poole, N. Loveridge, and C.M. Rose, et al. A single infusion of zoledronate prevents bone loss after stroke Stroke 38 5 May 2007 1519 1525
25. I.R. Reid, J.P. Brown, and P. Burckhardt, et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density N Engl J Med 346 9 Feb 28 2002 653 661
26. H.W. Kim, C.W. Park, and Y.S. Shin, et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis Nephron Clin Pract 102 1 2006 c21 c29
27. D.R. Van Wagoner, and J.M. Nerbonne Molecular basis of electrical remodeling in atrial fibrillation J Mol Cell Cardiol 32 6 Jun 2000 1101 1117 Review
28. R.E. Hewitt, A. Lissina, and A.E. Green, et al. The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood γδ T cells in response to aminobisphosphonates is inhibited by statins Clin Exp Immunol 139 1 Jan 2005 101 111
29. R.J. Aviles, D.O. Martin, and C. Apperson-Hansen, et al. Inflammation as a risk factor for atrial fibrillation Circulation 108 24 Dec 16 2003 3006 3010
30. J.J. Body, I. Diel, and R. Bell Profiling the safety and tolerability of bisphosphonates Semin Oncol 31 5 Suppl 10 Oct 2004 73 78 Review
31. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150